Bone Biologics Corporation — Net Income by Fiscal Year
21 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2c2dfc61-8b87-4560-bfcb-c65996fd8479/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-3.1M | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-008564 |
| FY 2024 | $-4.1M | 2024-01-01 – 2024-12-31 | evidence 0001493152-25-008383 |
| FY 2023 | $-8.9M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-007432 |
| FY 2022 | $-1.5M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-009799 |
| FY 2021 | $-1.6M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-006850 |
| FY 2020 | $-1.8M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-008887 |
| FY 2019 | $-3.4M | 2019-01-01 – 2019-12-31 | evidence 0001493152-20-004977 |
| FY 2018 | $-4.4M | 2018-01-01 – 2018-12-31 | evidence 0001493152-19-004221 |
| FY 2017 | $-60.6M | 2007-10-18 – 2018-03-31 | evidence 0001493152-18-006922 |
| FY 2016 | $50.0M | 2007-10-18 – 2017-03-31 | evidence 0001493152-17-005163 |
| FY 2015 | $32.9M | 2004-03-09 – 2016-03-31 | evidence 0001493152-16-009706 |
| FY 2014 | $12.0M | 2004-03-09 – 2015-03-31 | evidence 0001493152-15-001976 |
| FY 2013 | $-68.6k | 2007-10-18 – 2014-04-30 | evidence 0001376474-14-000220 |
| FY 2012 | $-62.7k | 2007-10-18 – 2013-04-30 | evidence 0001493152-13-001189 |
| FY 2011 | $-57.5k | 2007-10-19 – 2012-04-30 | evidence 0001387131-12-001886 |
| FY 2010 | $-897.7k | 2010-01-01 – 2010-12-31 | evidence 0001493152-14-003110 |
| FY 2009 | $-1.2M | 2009-01-01 – 2009-12-31 | evidence 0001493152-14-003110 |
| FY 2008 | $-1.0M | 2008-01-01 – 2008-12-31 | evidence 0001493152-14-003110 |
| FY 2007 | $-1.2M | 2007-01-01 – 2007-12-31 | evidence 0001493152-14-003110 |
| FY 2006 | $-476.5k | 2006-01-01 – 2006-12-31 | evidence 0001493152-14-003110 |
| FY 2005 | $-50.8k | 2005-01-01 – 2005-12-31 | evidence 0001493152-14-003110 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Bone Biologics Corporation — all facts · Revenue · Operating Income